Companies Supplying US with 100 Million Doses of COVID-19 Vaccine

Trump administration to provide up to $2.1 billion to Sanofi, GSK for vaccine production

The two companies' inoculation is combination of a vaccine based on Sanofi's flu shots and a complementary technology from GSK called an adjuvant, created to improve the vaccine's potency. If successful, US regulatory approval is anticipated in the first half of 2021. Sanofi will receive the bulk of the funding. "Today's investment supports our latest vaccine candidate, an adjuvanted product being developed by Sanofi and GSK, all the way through clinical trials and manufacturing, with the potential to bring hundreds of millions of safe and effective doses to the American people".

"On Wednesday, we received the first consignment of 34 Covaxine (BBV152 COVID vaccine) developed by Bharat Biotech International and on Friday, we received 20 covaxine (ZyCoV-D) developed by drug firm Zydus Cadila".

Director of the National Institutes of Health, Dr. Francis Collins, holds a model of the coronavirus as he testifies at a US Senate hearing to review Operation Warp Speed: the researching, manufacturing, and distributing of a safe and effective coronavirus vaccine, in Washington, DC, on July 2, 2020.

While clinical trials are underway, HHS said, manufacturing efforts would begin with a demonstration project-a parallel effort meant to speed up vaccine development.

The companies have agreed to carry out fill-finish manufacturing in the that vaccine doses are packaged and ready to ship immediately if clinical trials are successful and FDA authorizes use.

The U.S. government has also entered into a $1.95 billion deal with Pfizer and BioNTech to produce 100 million doses of a COVID-19 vaccine when approved. "So those are the ones we're investing in".

In May, French Junior Economy Minister Agnès Pannier-Runacher said it would be "unacceptable" that the United States may be the first nation to get access to a COVID-19 vaccine produced by Sanofi, which is a French company. However, health care providers could charge to administer the vaccine. We are expecting more vaccines from the companies soon.

"The (vaccine) doses would be manufactured in European countries including France, Belgium, Germany, and Italy", the companies said in a statement.

The Sanofi-GSK deal is for 100 million doses, at two per person, and gives the government an option to purchase an additional 500 million doses at an unspecified price.

"The global need for a vaccine to help prevent COVID-19 is massive, and no single vaccine or company will be able to meet the global demand alone", Thomas Triomphe, executive vice president and global head of Sanofi Pasteur, the company's vaccine division, said in the news release.



Latest news

Beyonce Black Is King Hair Makeup Is Already Iconic
After mounted anticipation, Queen Bey fans can now check out her full Black Is King album on Disney Plus . In the absence of much dialogue, it's the visuals that do much of the talking in " Black Is King ".

COVID-19 cases on the continent top 900,000: Africa CDC
Camp officers started sending campers household on June 24 and shut the camp on the 27th. The report said this was "relatively large" but doesn't clearly say if it was too many.

Horner: Perez's positive COVID-19 test "stark reminder" to F1
Racing Point's reverse drivers are Esteban Gutierrez and Stoffel Vandoorne, the test drivers on the books of engine suppliers Mercedes.

Jesse Lingard quotes Michael Jackson in heartfelt message to Manchester United fans
The England worldwide has seen limited game time this season and only has one year left on his £100,000-a-week deal. We did a skills DVD and it was him teaching us skills which was good.

Vietnam records first COVID-19 death after virus re-emerges - state media
State media said a makeshift hospital is being set up at a Danang sports center in anticipation of the outbreak worsening. Its pedestrian streets, adorned with lanterns, were empty and nonessential services and gatherings were banned.

Other news